Skip to main navigation Skip to search Skip to main content

Identification of novel inhibitors of fibroblast growth factor (FGF-2) binding to heparin and endothelial cell survival from a structurally diverse carbohybrid library

  • Paul V. Murphy
  • , Nigel Pitt
  • , Alan O'Brien
  • , Philomena M. Enright
  • , Amanda Dunne
  • , Stephen J. Wilson
  • , Rhona M. Duane
  • , Kathy M. O'Boyle
  • University College Dublin

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

24 Citations (Scopus)

Abstract

Inhibitors of FGF-2 binding to a heparin-albumin conjugate were identified by ELISA from a library of glucuronic acid derivatives. These compounds were also inhibitors of endothelial cell survival that is dependant on FGF-2 and heparin or heparan sulfate proteoglycans. The results indicate that these bioactive compounds may prove useful as lead structures for the further development of pharmaceutical agents capable of modulating biological activity of FGF-2.

Original languageEnglish
Pages (from-to)3287-3290
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume12
Issue number22
DOIs
Publication statusPublished - 18 Nov 2002
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Identification of novel inhibitors of fibroblast growth factor (FGF-2) binding to heparin and endothelial cell survival from a structurally diverse carbohybrid library'. Together they form a unique fingerprint.

Cite this